ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder
Condition(s):Generalized Anxiety DisorderLast Updated:June 30, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Generalized Anxiety DisorderLast Updated:June 30, 2010Completed
Condition(s):Psychosis; Agitation; DeliriumLast Updated:September 25, 2017Withdrawn
Condition(s):Status EpilepticusLast Updated:September 4, 2020Completed
Condition(s):Critical Limb IschemiaLast Updated:February 3, 2014Terminated
Condition(s):Brain Metastasis; Bladder Cancer; Breast Cancer; Cervical Cancer; Colon Cancer; HEENT Cancer; Lung Cancer; Melanoma; Pancreatic Cancer; Prostate Cancer; Rectal Cancer; Sarcoma; Testicular CancerLast Updated:February 22, 2016Completed
Condition(s):Bipolar Disorder IILast Updated:July 11, 2017Unknown status
Condition(s):HealthyLast Updated:July 27, 2016Completed
Condition(s):Septic PeritonitisLast Updated:April 27, 2021Completed
Condition(s):HealthyLast Updated:August 28, 2015Completed
Condition(s):Bipolar DisorderLast Updated:March 4, 2008Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.